Newbridge Financial Services Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$4 | – | 1201 |
|
|
2024
Q3 | $4 | Sell |
1
-1
| -50% | -$4 | ﹤0.01% | 654 |
|
|
2024
Q2 | $14 | Hold |
2
| – | – | ﹤0.01% | 1076 |
|
|
2024
Q1 | $118 | Hold |
2
| – | – | ﹤0.01% | 1142 |
|
|
2023
Q4 | $277 | Hold |
2
| – | – | ﹤0.01% | 1068 |
|
|
2023
Q3 | $1.1K | Hold |
2
| – | – | ﹤0.01% | 1148 |
|
|
2023
Q2 | $9.56K | Hold |
2
| – | – | ﹤0.01% | 896 |
|
|
2023
Q1 | $5.53K | Hold |
2
| – | – | ﹤0.01% | 1043 |
|
|
2022
Q4 | $5.43K | Hold |
2
| – | – | ﹤0.01% | 1052 |
|
|
2022
Q3 | $8K | Hold |
2
| – | – | ﹤0.01% | 959 |
|
|
2022
Q2 | $5K | Hold |
2
| – | – | ﹤0.01% | 1033 |
|
|
2022
Q1 | $7K | Hold |
2
| – | – | ﹤0.01% | 1036 |
|
|
2021
Q4 | $13K | Hold |
2
| – | – | 0.01% | 861 |
|
|
2021
Q3 | $19K | Hold |
2
| – | – | 0.01% | 686 |
|
|
2021
Q2 | $21K | Hold |
2
| – | – | 0.01% | 772 |
|
|
2021
Q1 | $40K | Buy |
+2
| New | +$40K | 0.03% | 455 |
|